← Back to Search

Behavioral Intervention

1 Session for Anxiety Disorders

N/A
Waitlist Available
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 days (measured at pre-treatment and post-treatment)
Awards & highlights

Study Summary

This study is evaluating whether a new method of treatment for phobias can be successfully applied to patients suffering from phobias of everyday objects.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 days (measured at pre-treatment and post-treatment)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 days (measured at pre-treatment and post-treatment) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Amygdala Reactivity
Subjective Fear Post-treatment Minus Pre-treatment
Secondary outcome measures
Fear Survey Schedule
Skin Conductance Response: Physiological Arousal Post-treatment Minus Pre-treatment
Stroop Task Post-treatment Minus Pre-treatment

Trial Design

3Treatment groups
Experimental Treatment
Group I: 5 sessionsExperimental Treatment1 Intervention
5 neuro-reinforcement sessions
Group II: 3 SessionsExperimental Treatment1 Intervention
3 neuro-reinforcement sessions
Group III: 1 SessionExperimental Treatment1 Intervention
1 neuro-reinforcement session
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Unconscious Neuro-reinforcement
2018
N/A
~30

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,532 Previous Clinical Trials
10,265,245 Total Patients Enrolled
32 Trials studying Anxiety Disorders
3,703 Patients Enrolled for Anxiety Disorders

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Treating Phobia With Multivoxel Neuro-reinforcement
Michelle Craske 2018. "Treating Phobia With Multivoxel Neuro-reinforcement". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03655262.
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top